Sage/Biogen depression drug yields positive results in postpartum depressionR&D, TherapeuticsSage Therapeutics and partner Biogen shared news that their Phase III Skylark study has yielded promising results for women suffering from severe postpartum depression (PPD). Read more June 1, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/06/BioSpacePPDphoto6-1-2022.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-06-01 11:35:062022-06-01 11:50:03Sage/Biogen depression drug yields positive results in postpartum depression
